Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1-KMT2A Interaction

Int J Mol Sci. 2023 Nov 17;24(22):16472. doi: 10.3390/ijms242216472.

Abstract

Menin/MEN1 is a scaffold protein that participates in proliferation, regulation of gene transcription, DNA damage repair, and signal transduction. In hematological malignancies harboring the KMT2A/MLL1 (MLLr) chromosomal rearrangements, the interaction of the oncogenic fusion protein MLLr with MEN1 has been shown to be essential. MEN1 binders inhibiting the MEN1 and KMT2A interaction have been shown to be effective against MLLr AML and B-ALL in experimental models and clinical studies. We hypothesized that in addition to the MEN1-KMT2A interaction, alternative mechanisms might be instrumental in the MEN1 dependency of leukemia. We first mined and analyzed data from publicly available gene expression databases, finding that the dependency of B-ALL cell lines on MEN1 did not correlate with the presence of MLLr. Using shRNA-mediated knockdown, we found that all tested B-ALL cell lines were sensitive to MEN1 depletion, independent of the underlying driver mutations. Most multiple myeloma cell lines that did not harbor MLLr were also sensitive to the genetic depletion of MEN1. We conclude that the oncogenic role of MEN1 is not limited to the interaction with KMT2A. Our results suggest that targeted degradation of MEN1 or the development of binders that induce global changes in the MEN1 protein structure may be more efficient than the inhibition of individual MEN1 protein interactions.

Keywords: B-cell acute lymphoblastic leukemia (B-ALL); menin/MEN1; multiple myeloma (MM); targeted therapy.

MeSH terms

  • Cell Line, Tumor
  • Humans
  • Leukemia / metabolism
  • Multiple Myeloma* / genetics
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
  • Transcription Factors / genetics

Substances

  • Transcription Factors
  • MEN1 protein, human
  • KMT2A protein, human

Grants and funding